COVID-19 could trigger a brain health time-bomb in the future. If so, what can we do now?
Learn about the unique challenges of COVID-19 on PD patients and tips on how best to prepare.
Stay ahead of the curve on the latest breakthroughs and testing availability.
Join the fight to end Alzheimer’s, Parkinson’s, and all brain diseases.
Amprion pioneers early detection to track the biomarkers of Parkinson’s, Alzheimer’s, and Lewy Body Dementia. Our test identifies the biomarkers long before symptoms. We consider all brain diseases exist on a spectrum called ParkinZheimer™.
AMPRION & SYNTap are registered trademarks of Amprion Inc. ©2007-2021 Amprion Inc. All rights reserved.
Privacy Policy | HIPAA PolicyAMPRION & SYNTap are registered trademarks of Amprion Inc. ©2007-2021 Amprion Inc. All rights reserved. | Privacy Policy
| HIPAA Policy
